[Positron emission tomography in the diagnosis of lung cancer].
BACKGROUND
Lung cancer is a common malignancy. Positron emission tomography (PET) has become an important tool in the staging of the disease with regard to operability and in order to determine radiation volume when surgery is not indicated.


METHODS
We have assessed and discuss results recently published in major international journals.


RESULTS
In approximately 60% of the patients, the planning of treatment is modified after a PET investigation.


CONCLUSIONS
In contrast to the state the art in most industrialised countries, dedicated PET is not available in Norway. Hence lung cancer is suboptimally treated.
Bach-Gansmo
Tore
T
Nukleaermedisinsk avdeling, Radiumhospitalet, 0310 Oslo. tore.bach-gansmo@klinmed.uio.no
Bogsrud
Trond Velde
TV
Aas
Magne
M
Jørgensen
Lars H
LH
Fischer
Barbara Malene
BM
D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D015201:Meta-Analysis as Topic; D016032:Randomized Controlled Trials as Topic; D014055:Tomography, Emission-Computed